Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03372720

NCT03372720
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are a woman who has been diagnosed with cervical, endometrial, vaginal, vulvar, or ovarian cancer and have finished all cancer treatment at least 6 months ago
  • You have had no signs of cancer coming back, confirmed by a pelvic exam within the last 3 months
  • You have had any type of uterus removal surgery (including full radical removal), with or without radiation therapy
  • You are experiencing painful sex and/or vaginal dryness that you would rate at least a 4 out of 10 in severity, which has been ongoing for at least 4 weeks, or you are unable to have sex at all because of pain

Who may not be able to join:

  • Your cancer has come back or spread to other parts of the body
  • You have been told you have a moderate or severe pelvic organ prolapse (stage 2 or higher), where pelvic organs have dropped out of their normal position
  • You have previously had pelvic reconstructive surgery that used a mesh implant
  • You have used hormone replacement therapy or vaginal estrogen products within the last 6 weeks before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
clinicaltrials_gov
Start date
11 May 2018
Est. completion
18 December 2019

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in genitourinary syndrome of menopause (GSM) symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov